Company intelligence / Profile preview

Rocky Mountain Biosystems

Wheat Ridge, Colorado, United Statescrunchbase.com ↗

Ownership: Private
Development stage: Other

Overview

Rocky Mountain Biosystems developed proprietary transdermal drug/vaccine delivery systems including the SAVE device—a wristwatch-sized, needle-free electromechanical system intended for rapid self-administration of vaccines during pandemics. The company also explored tissue sealing and cosmetic dermatology applications using magnetic induction and radiofrequency devices. Clinical results are limited in public domain; NIH funding was received to advance preclinical development of the SAVE platform.

Therapeutic areas: DermatologyInfectious Diseases
Modalities: DeviceTransdermal drug delivery technology
Industry: Therapeutic Medical Devices

Partnerships

National Institutes of Health/National Institute of Allergy and Infectious Diseases grant recipient

Beyond the preview

Go deeper on Rocky Mountain Biosystems.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Rocky Mountain Biosystems.

Explore the full profile